Docoh
Loading...

PYXS Pyxis Oncology

Company profile

PYXS stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

21 Oct 21
31 Dec 21
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
13 Oct 21 Cormorant Asset Management Common Stock Buy Acquire P Yes No 16 450,000 7.2M 1,118,854
13 Oct 21 Cormorant Asset Management Common Stock Conversion Acquire C Yes No 0 668,854 0 668,854
13 Oct 21 Cormorant Asset Management Series B Convertible Preferred Stock Common Stock Conversion Dispose C Yes No 0 668,854 0 0
13 Oct 21 World Investments B.V. Bayer Common Stock Conversion Acquire C No No 0 2,742,338 0 2,742,338
13 Oct 21 World Investments B.V. Bayer Series B Convertible Preferred Stock Common Stock Conversion Dispose C No No 0 6,076,072 0 0
13 Oct 21 World Investments B.V. Bayer Series A Convertible Preferred Stock Common Stock Conversion Dispose C No No 0 11,362,462 0 0
13 Oct 21 John L Flavin Common Stock Conversion Acquire C No No 0 2,388 0 171,610
13 Oct 21 John L Flavin Series B Convertible Preferred Stock Common Stock Conversion Dispose C No No 0 15,190 0 0
13 Oct 21 Chin Mark Common Stock Buy Acquire P Yes No 16 312,500 5M 1,745,761
13 Oct 21 Chin Mark Common Stock Conversion Acquire C Yes No 0 1,433,261 0 1,433,261

Financial reports

No filings

Current reports

No filings

Proxies

No filings